SinoMab Awarded the "Best Small and Mid-Cap Company" and "Best CEO" in the Selection of the "6th Hong Kong Golden Stocks Awards" and the "Listed Company with the Most Growth Potential" in the Selection of "2021 Sina Finance Golden Unicorn Best Hong Kong and US Listed Companies" SinoMab BioScience Limited Jan 11, 2022 16:55 HKT/SGT Read More
Clinical Evaluation of LeSoleil Against COVID-19 Suntrap Life Technologies Ltd Jan 11, 2022 12:00 HKT/SGT Read More
EC Healthcare expects to achieve a record-high sales volume in third quarter of FY22, Represents more than 40% Y-o-Y increase EC Healthcare Jan 10, 2022 08:18 HKT/SGT Read More
Clinical Evaluation of LeSoleil Against COVID-19 Suntrap Life Technologies Ltd Jan 06, 2022 14:00 HKT/SGT Read More
Eisai Enters Into Exclusive Licensing Agreement with Roivant Concerning Investigational Anticancer Agent H3B-8800, a Splicing Modulator Eisai Jan 06, 2022 10:09 HKT/SGT Read More
B-cell lymphoma clinical trials now open on the TrialWire Platform TrialWire Jan 05, 2022 17:10 HKT/SGT Read More
B-cell lymphoma clinical trials now open on the TrialWire Platform TrialWire Jan 05, 2022 16:00 JST Read More
Oculis appoints Mr. Webb Ding as Global Chief Operating Officer and General Manager (China) Oculis S.A. Jan 05, 2022 15:27 HKT/SGT Read More
冠科美博(Apollomics)首席执行官余国良博士当选为百华协会 (BayHelix Group) 董事会主席 Apollomics, Inc. Jan 04, 2022 10:12 HKT/SGT Read More
冠科美博(Apollomics)首席執行官余國良博士當選為百華協會 (BayHelix Group) 董事會主席 Apollomics, Inc. Jan 04, 2022 10:11 HKT/SGT Read More
Apollomics Inc. Announces CEO Guo-Liang Yu, PhD Appointed as Chairman of the Board for the BayHelix Group Apollomics, Inc. Jan 04, 2022 10:10 HKT/SGT Read More
Investigational Alzheimer's Disease Therapy Lecanemab Granted FDA Fast Track Designation Eisai Dec 24, 2021 08:26 HKT/SGT Read More